Predilytics is a Burlington, MA-based healthcare information technology company that applies patented machine-learning analytic tools to transform structured and unstructured client data and external sources into actionable insights. Its core product ingests diverse data to help healthcare organizations understand consumer behavior, optimize and precisely target care delivery, and improve population health. The company was founded in 2011 and is led by President and CEO Chris Coloian. On December 22, 2014, Predilytics secured an additional $10M Series C funding. The company intends to use the funds to continue to grow and develop its technology. The financing underscores continued investor support for its analytics platform and product development plans. Predilytics is a Burlington, MA-based advanced predictive analytics company founded in 2011 and led by Patrick Flynn, executive chairman. The company applies patented machine-learning analytic tools for healthcare organizations to optimize and target care delivery, increase revenue and control costs. Predilytics secured additional funding from Foundation Medical Partners; the amount of the funding was not disclosed. In conjunction with the transaction, Andrew D. Firlik, MD, Foundation Medical Partners managing partner, joined Predilytics' board of directors. The company intends to use the capital to grow the business and its customer base. Predilytics is also backed by Flybridge Capital Partners, Highland Capital Partners, Foundation Medical Partners, and Google Ventures. Predilytics is a U.S.-based healthcare data analytics and services company. Its products assist health plans and providers in identifying and prioritizing opportunities against key business initiatives, including improving appropriate documentation for disease burden, attracting and retaining plan membership, enhancing the effectiveness of care management, and reducing costly facility admissions and re-admissions. The company is led by President and CEO Christopher Coloian, Executive Chairman Patrick Flynn, CTO Doug Newell, COO Kirk Stanley and Chief Medical Officer Hari Sundram. Predilytics raised $6m in Series A financing. The company intends to use the funding to further expand its product offerings and grow operations with a focus on analytics, information technology, application development and account management.

Total raised

$16M

Funding rounds

3

Latest round

Series C

Latest activity

Dec 2014